SEARCH OUR PRODUCT CATALOG

ATP2B4-TFEB Fusion FISH Probe

The ATP2B4-TFEB Fusion FISH Probe is used to confirm a fusion of the ATP2B4 and TFEB genes. The fusion of the ATP2B4 and TFEB genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
ATP2B4-TFEB-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
ATP2B4-TFEB-20-RERE 20 (40 μL) 200 μL
ATP2B4-TFEB-20-REOR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-REGO 20 (40 μL) 200 μL
ATP2B4-TFEB-20-REGR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-REAQ 20 (40 μL) 200 μL
ATP2B4-TFEB-20-ORRE 20 (40 μL) 200 μL
ATP2B4-TFEB-20-OROR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-ORGO 20 (40 μL) 200 μL
ATP2B4-TFEB-20-ORAQ 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GORE 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GOOR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GOGO 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GOGR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GOAQ 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GRRE 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GROR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GRGO 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GRGR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-GRAQ 20 (40 μL) 200 μL
ATP2B4-TFEB-20-AQRE 20 (40 μL) 200 μL
ATP2B4-TFEB-20-AQOR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-AQGO 20 (40 μL) 200 μL
ATP2B4-TFEB-20-AQGR 20 (40 μL) 200 μL
ATP2B4-TFEB-20-AQAQ 20 (40 μL) 200 μL

ATP2B4 Gene Summary

The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Gene Name: ATPase Plasma Membrane Ca2+ Transporting 4

Chromosome: CHR1: 203595914 -203713209

Locus: 1q32.1

TFEB Gene Summary

The Transcription Factor EB (TFEB) gene is located on chr6 :41651715-41703997 at 6p21.1.

Gene Name: Transcription Factor EB

Chromosome: CHR6: 41651715 -41703997

Locus: 6p21.1

Gene Diseases

The ATP2B4 TFEB Fusion has been associated with the following diseases:

Disease Name
Uterine Corpus Endometrial Carcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays

Renal cell carcinomas with MITF family abnormalities display diverse morphologies. In order to better understand the association between MITF alterations and clinicopathologic characteristics, this team performed FISH analysis on 85 renal tumors using our TFE3 and TFEB break apart probes.

Histological and molecular characterization of TFEB-rearranged renal cell carcinomas

Renal cell carcinomas (RCCs) have historically been classified based on their morphology, anatomical location, or background renal disease. However, recurrent genetic abnormalities are being described more frequently in RCC, and have proven useful in the genetic classification of different RCC subsets. This study sought to clarify the underlying genetics of one such RCC subtype, TFEB-rearranged RCC. As part of genetic testing, Empire Genomics’ TFEB break apart probe was used to detect TFEB translocations in two RCC tumors, helping to verify the presence of a TFEB rearrangement in one case.

Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization

Renal cell carcinoma (RCC) can be subdivided into several categories based on morphology, histology, protein expression, and genetics. Although RCC can usually be classified using histological and immunohistochemical analysis, differential diagnosis can prove challenging in ambiguous cases. This study evaluated the efficacy of FISH in RCC classification via analysis of 539 RCC tumors. Empire Genomics’ TFEB break apart probes were used to detect TFEB translocations.

Clinicopathological Characterization of Renal Cell Carcinoma in Young Adults: a contemporary update and review of literature

Compared to adult renal cell carcinoma (RCC), pediatric and young adult RCC is fairly rare and poorly characterized. This team wanted to explore the genetic, molecular, and clinical spectrum of childhood and young adult RCC. They analyzed 68 RCC patients, all age 30 years or younger, using IHC and FISH. Our TFE3 and TFEB break apart FISH probes were used to detect rearrangements of the genes in cases that were morphologically suspicious for TFE3/TFEB translocations.